When you receive a vial of compounded semaglutide, how do you know what's actually inside matches what's on the label? The answer lies in independent laboratory testing — and the results from 2025–2026 are more reassuring than you might expect.
This article examines what independent testing has revealed about compounded semaglutide quality, what the testing process involves, and how to use this information as an informed consumer.
What Independent Lab Testing Measures
When a compounded medication undergoes independent laboratory analysis, several key parameters are evaluated:
Potency (Active Ingredient Concentration)
This is the most critical measurement. Potency testing determines whether the actual concentration of semaglutide in the vial matches the labeled concentration. The USP (United States Pharmacopeia) standard for compounded sterile preparations is typically 90%–110% of the labeled potency. A vial labeled as 2.5mg/mL of semaglutide should contain between 2.25mg/mL and 2.75mg/mL to meet this standard.
Purity
Purity testing identifies any degradation products, impurities, or contaminants in the formulation. High-performance liquid chromatography (HPLC) is the standard analytical method, which can detect impurities at very low levels. A well-compounded product should show purity levels above 95%, with most quality operations achieving 98%+ purity.
Sterility
For injectable medications, sterility testing is non-negotiable. This involves incubating samples in growth media to confirm the absence of bacterial, fungal, and yeast contamination. USP <71> defines the standard methodology. Sterility test results typically take 14 days to complete, which is why pharmacies must have robust aseptic technique — they can't wait for sterility results before dispensing every batch.
Endotoxin Testing
Endotoxins are bacterial cell wall fragments that can cause fever, inflammation, and in severe cases, septic shock when injected. The Limulus Amebocyte Lysate (LAL) test or recombinant Factor C assay detects endotoxins at extremely low levels. USP <85> sets the limits for injectable preparations.
pH and Osmolality
These measurements confirm that the formulation is compatible with injection. Proper pH and osmolality reduce injection site pain and irritation. Semaglutide formulations typically target a pH between 7.0 and 8.0.
What the Data Shows: 2025–2026 Testing Results
Several independent analyses of compounded semaglutide have been published or reported in 2025 and 2026. While individual results vary by pharmacy and batch, the overall picture is encouraging:
Key Findings From Independent Testing
Potency: The majority of samples from established, accredited compounding pharmacies fall within the 90%–110% USP potency range. Pharmacies with PCAB accreditation or equivalent quality programs tend to cluster closer to 100% — typically 95%–105%.
Sterility: Pass rates for sterility testing are high among pharmacies following USP <797> standards, particularly those with ISO 5 classified cleanroom environments and robust environmental monitoring programs.
Purity: HPLC analysis of properly stored compounded semaglutide shows purity levels comparable to the active pharmaceutical ingredient (API) specifications, typically above 97%.
Where Quality Varies
Not all testing results have been uniformly positive. Quality variation tends to correlate with specific factors:
Pharmacy quality systems. Pharmacies with comprehensive quality assurance programs — including routine potency testing, environmental monitoring, and personnel competency assessments — produce more consistent results than those meeting only minimum requirements.
API sourcing. The quality of the raw semaglutide active pharmaceutical ingredient matters. Pharmacies sourcing API from FDA-registered suppliers with Drug Master Files (DMFs) and Certificates of Analysis from the manufacturer tend to produce higher-quality finished products.
Storage and handling. Semaglutide is a peptide that can degrade if exposed to heat, light, or improper storage conditions. Testing of properly cold-chain-managed vials shows significantly better stability results than products that may have experienced temperature excursions during shipping.
How to Use This Information as a Patient
Ask for Certificates of Analysis
A Certificate of Analysis (COA) documents the testing results for a specific batch of medication. Quality-focused pharmacies generate COAs for every batch and can provide them upon request. Your telehealth provider should be able to facilitate this request.
A COA should include, at minimum: the batch or lot number matching your vial, potency results showing the actual vs. labeled concentration, sterility test results with the test method used, endotoxin test results, and the name and accreditation of the testing laboratory.
Understand Beyond-Use Dating
Beyond-use dating (BUD) tells you how long the compounded medication remains safe and effective after preparation. A pharmacy that assigns BUD based on actual stability testing data — rather than default USP timeframes — is demonstrating a higher commitment to quality. Ask your provider how your medication's BUD was determined.
Look for Third-Party Testing
Some pharmacies use internal (in-house) laboratories for testing, while others send samples to independent third-party laboratories. Third-party testing provides an additional layer of objectivity. Pharmacies that voluntarily use third-party verification are signaling confidence in their product quality.
The API Supply Chain: Where Semaglutide Starts
Compounded semaglutide begins as an active pharmaceutical ingredient (API) — the raw semaglutide powder that pharmacies then formulate into injectable solutions. The quality of this starting material is foundational.
Reputable compounding pharmacies source semaglutide API from:
FDA-registered facilities. API manufacturers registered with the FDA have undergone facility inspections and maintain compliance with manufacturing standards.
Suppliers with Drug Master Files. A DMF filed with the FDA contains detailed information about the manufacturing process, quality controls, and specifications for the API. While the DMF itself is confidential, its existence provides a level of regulatory accountability.
COA-verified batches. Each batch of API should come with its own Certificate of Analysis from the manufacturer, confirming identity, purity, potency, and the absence of specified impurities.
What About "Research Grade" Semaglutide?
Some online sellers offer "research grade" or "peptide grade" semaglutide at steep discounts. These products are not intended for human use, are not manufactured under pharmaceutical-grade conditions, and should never be injected. Legitimate compounding pharmacies use pharmaceutical-grade API exclusively.
The Quality Trajectory: Getting Better Over Time
One of the most encouraging trends in the compounded GLP-1 space is that quality is improving. Several factors are driving this trajectory:
Market maturation. As the industry has grown from a niche market to a multi-billion-dollar sector, investment in quality infrastructure has increased. More pharmacies are pursuing voluntary accreditations, investing in advanced analytical equipment, and hiring specialized personnel.
Regulatory attention. Increased FDA scrutiny — including the 503B exclusion proposal — has incentivized pharmacies to strengthen their quality programs. Pharmacies that want to remain competitive are differentiating on quality, not just price.
Consumer awareness. Patients are becoming more informed about what to look for in a compounding pharmacy. This consumer pressure drives quality improvements as pharmacies compete for trust.
Industry standards development. Professional organizations have published updated guidance on peptide compounding, providing clearer standards for pharmacies to follow.
The Bottom Line on Purity
Independent laboratory testing shows that compounded semaglutide from reputable, accredited pharmacies generally meets quality standards for potency, purity, and sterility. The key word is "reputable" — pharmacy selection matters enormously. By asking for Certificates of Analysis, verifying pharmacy credentials, and choosing providers that partner with quality-focused pharmacies, you can have confidence in the product you're receiving.